Organogenesis Holdings Inc (ORGO)
2.28
-0.03
(-1.30%)
USD |
NASDAQ |
May 09, 16:00
2.28
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Enterprise Value: 263.27M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 263.27M |
| May 08, 2024 | 267.23M |
| May 07, 2024 | 284.38M |
| May 06, 2024 | 277.78M |
| May 03, 2024 | 290.98M |
| May 02, 2024 | 290.98M |
| May 01, 2024 | 293.62M |
| April 30, 2024 | 272.50M |
| April 29, 2024 | 286.36M |
| April 26, 2024 | 272.50M |
| April 25, 2024 | 263.93M |
| April 24, 2024 | 355.64M |
| April 23, 2024 | 355.64M |
| April 22, 2024 | 354.32M |
| April 19, 2024 | 345.08M |
| April 18, 2024 | 339.81M |
| April 17, 2024 | 330.57M |
| April 16, 2024 | 339.81M |
| April 15, 2024 | 326.61M |
| April 12, 2024 | 342.44M |
| April 11, 2024 | 358.28M |
| April 10, 2024 | 351.68M |
| April 09, 2024 | 347.72M |
| April 08, 2024 | 354.32M |
| April 05, 2024 | 335.85M |
| Date | Value |
|---|---|
| April 04, 2024 | 331.89M |
| April 03, 2024 | 327.93M |
| April 02, 2024 | 306.82M |
| April 01, 2024 | 331.89M |
| March 28, 2024 | 337.17M |
| March 27, 2024 | 326.61M |
| March 26, 2024 | 308.13M |
| March 25, 2024 | 308.13M |
| March 22, 2024 | 306.82M |
| March 21, 2024 | 313.41M |
| March 20, 2024 | 331.89M |
| March 19, 2024 | 325.29M |
| March 18, 2024 | 325.29M |
| March 15, 2024 | 338.49M |
| March 14, 2024 | 337.17M |
| March 13, 2024 | 358.28M |
| March 12, 2024 | 350.36M |
| March 11, 2024 | 355.64M |
| March 08, 2024 | 372.80M |
| March 07, 2024 | 375.44M |
| March 06, 2024 | 338.49M |
| March 05, 2024 | 329.25M |
| March 04, 2024 | 342.44M |
| March 01, 2024 | 347.72M |
| February 29, 2024 | 433.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
216.21M
Minimum
Mar 24 2023
2.971B
Maximum
May 03 2021
779.56M
Average
518.98M
Median
Jan 29 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -13.29M |
| Oragenics Inc | 4.605M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.568M |
| Revenue (Quarterly) | 99.65M |
| Total Expenses (Quarterly) | 100.92M |
| EPS Diluted (Quarterly) | -0.0043 |
| Gross Profit Margin (Quarterly) | 72.13% |
| Profit Margin (Quarterly) | -0.57% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 4.14% |
| Normalized Earnings Yield | 1.564 |